Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3582]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to...
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
29 Jan 2015
Optimizing Survival in Advanced Prostate Cancer: Conclusion
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Immunotherapy of cancer: recent progress and future challenges
Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015
ecancermedicalscience editor's choice for December 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for December 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Dec 2014
UICC 2014 conference report
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
UICC 2014 conference report ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Dec 2014
Cancer and the immune system: exploring the landscape of cancer immunology
Dr Jonathan Cebon - Ludwig Institute for Cancer Research, Melbourne, Australia
Cancer and the immune system: exploring the landscape of cancer immunology ( Dr Jonathan Cebon - Ludwig Institute for Cancer Research, Melbourne, Australia )
17 Dec 2014
Comment: SABCS 2014 Highlights
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: SABCS 2014 Highlights ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )
16 Dec 2014
Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Kent Osborne - Baylor College of Medicine, Houston, USA )
16 Dec 2014
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple...
Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014
Combination of eribulin and capecitabine provides clinical benefit for women...
Dr Chris Twelves - St James's Hospital, Leeds, UK
Combination of eribulin and capecitabine provides clinical benefit for women with metastatic breast cancer ( Dr Chris Twelves - St James's Hospital, Leeds, UK )
12 Dec 2014
Ovarian suppression with tamoxifen reduced recurrence for some women with...
Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia
Ovarian suppression with tamoxifen reduced recurrence for some women with premenopausal breast cancer ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2014
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation